Prudential Financial Inc. Grows Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Prudential Financial Inc. grew its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 6.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 808,658 shares of the company’s stock after buying an additional 46,635 shares during the quarter. Prudential Financial Inc.’s holdings in Pediatrix Medical Group were worth $10,610,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Quest Partners LLC raised its position in Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP increased its holdings in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares in the last quarter. AlphaQuest LLC lifted its stake in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after purchasing an additional 2,012 shares during the period. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 5.8 %

MD opened at $14.15 on Friday. The company has a market cap of $1.21 billion, a PE ratio of -11.79, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The company has a 50-day moving average price of $14.40 and a 200 day moving average price of $13.65. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on MD shares. Truist Financial lifted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a report on Friday, February 21st. Macquarie initiated coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Finally, UBS Group boosted their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.